AU672862B2 - Cyclodextrin and polymer based drug delivery system - Google Patents
Cyclodextrin and polymer based drug delivery systemInfo
- Publication number
- AU672862B2 AU672862B2 AU56841/94A AU5684194A AU672862B2 AU 672862 B2 AU672862 B2 AU 672862B2 AU 56841/94 A AU56841/94 A AU 56841/94A AU 5684194 A AU5684194 A AU 5684194A AU 672862 B2 AU672862 B2 AU 672862B2
- Authority
- AU
- Australia
- Prior art keywords
- defined above
- alkyl
- cyclodextrin
- composition
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medical Informatics (AREA)
- Ophthalmology & Optometry (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/984,445 US5332582A (en) | 1990-06-12 | 1992-12-02 | Stabilization of aminosteroids for topical ophthalmic and other applications |
| US984445 | 1992-12-02 | ||
| US15516793A | 1993-11-19 | 1993-11-19 | |
| US155167 | 1993-11-19 | ||
| PCT/US1993/011651 WO1994012217A1 (en) | 1992-12-02 | 1993-12-01 | Cyclodextrin and polymer based drug delivery system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU5684194A AU5684194A (en) | 1994-06-22 |
| AU672862B2 true AU672862B2 (en) | 1996-10-17 |
Family
ID=26852057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU56841/94A Ceased AU672862B2 (en) | 1992-12-02 | 1993-12-01 | Cyclodextrin and polymer based drug delivery system |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0674528A4 (ja) |
| JP (1) | JPH08503951A (ja) |
| CN (1) | CN1103316A (ja) |
| AU (1) | AU672862B2 (ja) |
| CA (1) | CA2150554A1 (ja) |
| WO (1) | WO1994012217A1 (ja) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW434023B (en) * | 1995-09-18 | 2001-05-16 | Novartis Ag | Preserved ophthalmic composition |
| JP3940209B2 (ja) * | 1996-11-14 | 2007-07-04 | 株式会社資生堂 | 可溶化化粧料 |
| GB9711643D0 (en) * | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| CN1328443A (zh) * | 1998-11-23 | 2001-12-26 | 宝洁公司 | 皮肤除臭和卫生消毒组合物 |
| US6656456B2 (en) * | 1998-11-23 | 2003-12-02 | The Procter & Gamble Company | Skin deodorizing compositions |
| AU785285B2 (en) * | 2000-03-10 | 2006-12-21 | Sun Pharma Global Fze | Methods and compositions for treating and preventing posterior segment ophthalmic disorders |
| SI1278549T1 (sl) | 2000-05-02 | 2009-04-30 | Theravance Inc | Sestavek, ki vsebuje ciklodekstrin in glikopeptidni antibiotik |
| AU2001259298A1 (en) | 2000-05-02 | 2001-11-12 | Advanced Medicine, Inc. | Polyacid glycopeptide derivatives |
| UA75083C2 (uk) | 2000-06-22 | 2006-03-15 | Тераванс, Інк. | Похідні глікопептидфосфонатів |
| WO2001098327A2 (en) | 2000-06-22 | 2001-12-27 | Theravance, Inc. | Glycopeptide carboxy-saccharide derivatives |
| WO2001098329A1 (en) | 2000-06-22 | 2001-12-27 | Theravance, Inc. | Polyhydroxy glycopeptide derivatives |
| US6872804B2 (en) | 2000-06-22 | 2005-03-29 | Theravance, Inc. | Glycopeptide disulfide and thioester derivatives |
| AU2001288120A1 (en) * | 2000-09-26 | 2002-04-08 | Kyorin Pharmaceutical Co. Ltd. | Liquid prednisolone sodium phosphate preparation |
| WO2002092106A1 (en) * | 2001-05-11 | 2002-11-21 | Pacific Pharmaceuticals Limited | Taste masking pharmaceutical composition |
| JP4564920B2 (ja) * | 2003-04-18 | 2010-10-20 | 株式会社最先端医学研究所 | 眼に適用する疾患治療剤 |
| US6933289B2 (en) | 2003-07-01 | 2005-08-23 | Allergan, Inc. | Inhibition of irritating side effects associated with use of a topical ophthalmic medication |
| WO2006040839A1 (ja) * | 2004-10-15 | 2006-04-20 | Advanced Medicine Research Institute | 眼疾患処置用点眼剤及びキット |
| JP2007177149A (ja) * | 2005-12-28 | 2007-07-12 | Shield Lab:Kk | チオクト酸又はジヒドロリポ酸と分岐鎖シクロデキストリンとの包接化合物 |
| US20070202186A1 (en) | 2006-02-22 | 2007-08-30 | Iscience Interventional Corporation | Apparatus and formulations for suprachoroidal drug delivery |
| WO2009079679A2 (de) | 2007-12-21 | 2009-07-02 | Aop Orphan Pharmaceuticals Ag | Pharmazeutische zusammensetzung |
| US10201548B2 (en) | 2009-03-06 | 2019-02-12 | Sun Pharma Global Fze | Methods for treating ocular inflammatory diseases |
| US10980818B2 (en) | 2009-03-06 | 2021-04-20 | Sun Pharma Global Fze | Methods for treating ocular inflammatory diseases |
| EP3520749A1 (en) | 2010-10-15 | 2019-08-07 | Clearside Biomedical, Inc. | Device for ocular access |
| MX2015005839A (es) | 2012-11-08 | 2015-12-17 | Clearside Biomedical Inc | Metodos y dispositivos para el tratamiento de trastornos oculares en sujetos humanos. |
| TW201440811A (zh) * | 2013-02-12 | 2014-11-01 | Ys Pharmtech | 腎上腺素製劑藥品 |
| CN105246529B (zh) | 2013-05-03 | 2019-06-14 | 科尼尔赛德生物医学公司 | 用于眼部注射的设备和方法 |
| US10010447B2 (en) | 2013-12-18 | 2018-07-03 | Novartis Ag | Systems and methods for subretinal delivery of therapeutic agents |
| CN103990137A (zh) * | 2014-04-30 | 2014-08-20 | 福建融和药业有限公司 | 一种粘膜粘附性聚合物眼用药物的缓释剂 |
| WO2017139375A1 (en) | 2016-02-10 | 2017-08-17 | Clearside Biomedical, Inc. | Ocular injection kit, packaging, and methods of use |
| WO2017192565A1 (en) | 2016-05-02 | 2017-11-09 | Clearside Biomedical, Inc. | Systems and methods for ocular drug delivery |
| CN110177527B (zh) | 2016-08-12 | 2022-02-01 | 科尼尔赛德生物医学公司 | 用于调节药剂递送用针的插入深度的装置和方法 |
| WO2018204515A1 (en) | 2017-05-02 | 2018-11-08 | Georgia Tech Research Corporation | Targeted drug delivery methods using a microneedle |
| CN109136177B (zh) * | 2018-08-03 | 2021-09-17 | 湖南大学 | 一种地塞米松缓释体系以及一种成骨分化诱导液和应用 |
| RU2740287C1 (ru) * | 2019-08-30 | 2021-01-12 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | 3д-матриксная структура для доставки лекарственных препаратов |
| CN115380899A (zh) * | 2022-08-30 | 2022-11-25 | 陕西科技大学 | 一种凝胶型腐植酸缓释农药及其制备方法 |
| WO2024097388A1 (en) * | 2022-11-03 | 2024-05-10 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Systems and methods for monitoring fatty acid metabolism |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4383992A (en) * | 1982-02-08 | 1983-05-17 | Lipari John M | Water-soluble steroid compounds |
| WO1989006964A1 (en) * | 1988-02-08 | 1989-08-10 | Insite Vision, Inc. | Ophthalmic suspensions |
| US4983586A (en) * | 1987-12-30 | 1991-01-08 | University Of Florida | Pharmaceutical formulations for parenteral use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ225045A (en) * | 1987-07-01 | 1990-06-26 | Janssen Pharmaceutica Nv | Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent |
| ATE100712T1 (de) * | 1989-05-24 | 1994-02-15 | Innovet Inc | Hypoallergene anaesthesierende/hypnotische steroide arzneizubereitung. |
| GB9012663D0 (en) * | 1990-06-07 | 1990-08-01 | Erba Carlo Spa | Galenic formulations containing cyclodextrins |
-
1993
- 1993-12-01 EP EP94902482A patent/EP0674528A4/en not_active Withdrawn
- 1993-12-01 CA CA002150554A patent/CA2150554A1/en not_active Abandoned
- 1993-12-01 WO PCT/US1993/011651 patent/WO1994012217A1/en not_active Application Discontinuation
- 1993-12-01 AU AU56841/94A patent/AU672862B2/en not_active Ceased
- 1993-12-01 JP JP6513478A patent/JPH08503951A/ja active Pending
- 1993-12-02 CN CN93120402A patent/CN1103316A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4383992A (en) * | 1982-02-08 | 1983-05-17 | Lipari John M | Water-soluble steroid compounds |
| US4983586A (en) * | 1987-12-30 | 1991-01-08 | University Of Florida | Pharmaceutical formulations for parenteral use |
| WO1989006964A1 (en) * | 1988-02-08 | 1989-08-10 | Insite Vision, Inc. | Ophthalmic suspensions |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0674528A1 (en) | 1995-10-04 |
| WO1994012217A1 (en) | 1994-06-09 |
| JPH08503951A (ja) | 1996-04-30 |
| EP0674528A4 (en) | 1996-06-26 |
| AU5684194A (en) | 1994-06-22 |
| CN1103316A (zh) | 1995-06-07 |
| CA2150554A1 (en) | 1994-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU672862B2 (en) | Cyclodextrin and polymer based drug delivery system | |
| US5538721A (en) | Stabilization of aminosteroids for topical ophthalmic and other applications | |
| Loftssona et al. | Cyclodextrins in ophthalmic drug delivery | |
| Loftsson et al. | Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye | |
| US5576311A (en) | Cyclodextrins as suspending agents for pharmaceutical suspensions | |
| DE69324824T2 (de) | Weichgemachtes bioerodierbares system zur kontrollierten freigabe | |
| JP5469458B2 (ja) | 高分子ミセルクラスタ及びそれらの薬剤への使用 | |
| US5631297A (en) | Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same | |
| JP2007532648A (ja) | 眼の後部へのドラッグデリバリー | |
| JP3529142B2 (ja) | シクロデキストリンを含むガレヌス製剤 | |
| Jarho et al. | Modified β‐cyclodextrin (SBE7‐β‐CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits | |
| US20040152664A1 (en) | Prednisolone compositions | |
| WO2005011617A2 (en) | Transmucosal dosage forms for brain-targeted steroid chemical delivery systems | |
| US5977180A (en) | Anandamide analog compositions and method of treating intraocular hypertension using same | |
| EP0676952B1 (en) | Bioerodible controlled delivery system | |
| AU743204B2 (en) | Controlled release of ophthalmic compositions | |
| CN115837027A (zh) | 一种眼用地塞米松药物组合物 | |
| EP2994109B1 (en) | Aqueous ophthalmic formulations based on azithromycin | |
| Erdoğar et al. | Cyclodextrins in drug delivery | |
| Loftsson et al. | 2-Hydroxypropyl-6-cyclodextrin: Properties and Usage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |